🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.

Some professionals said the demand for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Content Elimination

Based on TikTok, the service has removed violative material and banned associated hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Digital Marketplace Activities

Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.

After minutes of entering one community, a vendor posted WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, health issues or previous experience.

Product Details and Costs

Within these communities, posts display black plastic packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram said it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to potentially significant health risks”.